Hydroxytyrosol
- Generic Name
- Hydroxytyrosol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H10O3
- CAS Number
- 10597-60-1
- Unique Ingredient Identifier
- QEU0NE4O90
- Background
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Strategic interventions in clinical randomized trials for metabolic dysfunction-associated ...
References cover NAFLD epidemiology, diagnosis, and treatment in children, including randomized controlled trials and systematic reviews. Topics include prevalence, risk factors, therapeutic targets, and interventions like losartan, probiotics, and lifestyle modifications. Key studies assess the efficacy of vitamin E, metformin, and docosahexaenoic acid in pediatric NAFLD.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath